Literature DB >> 22508887

Topical psoralen plus UV-A therapy for tyrosine kinase inhibitor-induced hand-foot syndrome.

Willemijn E M Bos, Tamar E C Nijsten, Maja J A de Jonge, A P Hamberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22508887     DOI： 10.1001/archdermatol.2011.3482

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  4 in total

Review 1.  An overview of the efficacy of phototherapy in oncodermatology.

Authors:  Candice Park; Abraham M Korman; Brittany L Dulmage
Journal:  Support Care Cancer       Date:  2022-02-02       Impact factor: 3.603

Review 2.  Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.

Authors:  B McLellan; F Ciardiello; M E Lacouture; S Segaert; E Van Cutsem
Journal:  Ann Oncol       Date:  2015-06-01       Impact factor: 32.976

3.  Clinical study for external Chinese herbal medicine LC09 treating hand-foot skin reaction associated with the antitumor targeted drugs: Protocol for a prospective, randomized, controlled, double-blind, and monocentric clinical trial.

Authors:  Gui Wang; Liqun Jia; Yuying Pei; Ran Yu; Yu Gao; Chao Deng; Yanni Lou
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

Review 4.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.